Ligand validation:3ZPR

Y01: CHOLESTEROL HEMISUCCINATE

Y01 is a Ligand Of Interest in 3ZPR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZPR_Y01_A_401	47%	18%	0.215	0.956	1.23	2.42	3	13	1	0	100%	1
3ZPR_Y01_B_401	30%	26%	0.281	0.946	1.16	1.97	2	13	2	0	100%	1
3ZPR_Y01_A_402	19%	34%	0.286	0.883	1.28	1.42	2	7	1	0	100%	1
3ZPR_Y01_B_402	13%	36%	0.371	0.912	1.15	1.46	2	8	0	0	100%	1
2Y00_Y01_B_401	50%	26%	0.195	0.946	1.24	1.91	3	14	1	0	100%	1
2Y01_Y01_A_401	49%	27%	0.208	0.956	1.24	1.82	3	15	1	0	100%	1
2Y03_Y01_B_401	48%	25%	0.213	0.957	1.21	1.97	3	13	2	0	100%	1
2Y04_Y01_B_401	45%	24%	0.203	0.935	1.35	1.93	4	15	2	0	100%	1
3ZPQ_Y01_A_401	34%	25%	0.271	0.955	1.1	2.07	2	11	1	0	100%	1
4XNV_Y01_A_1103	46%	28%	0.175	0.911	1.9	1.15	9	3	0	0	100%	1
6QD5_Y01_A_408	46%	26%	0.149	0.883	1.42	1.71	6	13	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.